XML 56 R40.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Goodwill and Intangible Assets (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of acquired intangible assets | Components of the Company’s acquired intangible assets are comprised of the following:
|  | December 31, 2023 |  | December 31, 2022
|  | Gross |  | Accumulated amortization and impairment charges |  | Net |  | Gross |  | Accumulated amortization and impairment charges |  | Net
Utrophin program acquired(1) |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4,015 |  |  | $ | (4,015) |  |  | $ | — |
Discuva platform acquired(2) |  | 13,583 |  |  | (13,583) |  |  | — |  |  | 12,900 |  |  | (12,900) |  |  | — |
Option over non-financial asset |  | 859 |  |  | (859) |  |  | — |  |  | 816 |  |  | (816) |  |  | — |
Other intangibles |  | 140 |  |  | (140) |  |  | — |  |  | 133 |  |  | (133) |  |  | — |
|  | $ | 14,582 |  |  | $ | (14,582) |  |  | $ | — |  |  | $ | 17,864 |  |  | $ | (17,864) |  |  | $ | — |
(1) During the year ended December 31, 2023, the Company dissolved the wholly-owned subsidiary, Muox Limited, a dormant entity. The Utrophin program intangible assets, which arose from the Muox Limited acquisition were fully impaired and have been removed from the Company’s accounting records. (2) In conjunction with the significant change in the Company’s strategy and shift in focus to the therapeutic area of oncology, the Company determined that it would cease further investment in the Discuva Platform. Management concluded that the carrying amount of the acquired Discuva Platform intangible asset may not be recoverable and performed an assessment to calculate the fair value of the asset using a probability-weighted approach which was compared to the carrying value of the asset. An impairment charge of $8,468 which represented the carrying value of the Discuva Platform was recognized during the year ended December 31, 2022. This impairment charge is presented as impairment of intangible assets in the consolidated statements of operations and comprehensive loss.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration